贛鋒鋰業(002460.SZ):擬設合資公司 在豐城投建年產5萬噸鋰電新能源材料項目
格隆匯6月8日丨贛鋒鋰業(002460.SZ)公佈,公司與豐城市政府於2021年6月8日簽署了《投資合同書》和《投資補充合同》,經雙方充分協商,本着“誠信合作、互惠互利,共同開發”的原則,在平等、自願的基礎上達成一致,約定公司在豐城市政府轄區內設立合資公司(具體以工商登記為準)並投資建設年產5萬噸鋰電新能源材料項目。
公司設立合資公司在豐城投資建設年產5萬噸鋰電新能源材料項目,將進一步擴大公司鋰鹽產品生產規模和市場份額,保障公司長期穩定發展,有利於提高公司核心競爭力和盈利能力,符合公司發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.